{"entity":{"type":"insider","cik":"0001992908","url":"/insider/0001992908","json_url":"/insider/0001992908.json","name":"Lenz Robert A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2024-09-16","last":"2025-02-20","span_basis":"filed_date"},"name_variants":[{"name":"Lenz Robert A.","source":"filing","n_filings":4,"first_seen":"2024-09-16","last_seen":"2025-02-20"}],"transactions":[{"id":4046378,"accession":"0001610717-25-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000028","line_url":"/filing/0001610717-25-000028#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992908","owner_name":"Lenz Robert A.","owner_display_name":"Lenz Robert A.","owner_url":"/insider/0001992908","role":"Officer (Head of R&D)","role_mark":"O","role_mark_label":"Officer (Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5614.0,"shares_display":"5,614","price_per_share":1.6714,"price_display":"1.67","price_state":"stated","total_value":9383.2396,"total_display":"9,383.24","total_whole":"9,383","shares_owned_after":309092.0,"shares_owned_after_display":"309,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-20","scope":"insider"},{"id":2290752,"accession":"0001610717-24-000505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000505","line_url":"/filing/0001610717-24-000505#line-2","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992908","owner_name":"Lenz Robert A.","owner_display_name":"Lenz Robert A.","owner_url":"/insider/0001992908","role":"Officer (Head of R&D)","role_mark":"O","role_mark_label":"Officer (Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8260.0,"shares_display":"8,260","price_per_share":15.0851,"price_display":"15.09","price_state":"stated","total_value":124602.926,"total_display":"124,602.93","total_whole":"124,603","shares_owned_after":314706.0,"shares_owned_after_display":"314,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-10","filed_date":"2024-10-11","scope":"insider"},{"id":2290747,"accession":"0001610717-24-000505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000505","line_url":"/filing/0001610717-24-000505#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992908","owner_name":"Lenz Robert A.","owner_display_name":"Lenz Robert A.","owner_url":"/insider/0001992908","role":"Officer (Head of R&D)","role_mark":"O","role_mark_label":"Officer (Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5563.0,"shares_display":"5,563","price_per_share":15.0112,"price_display":"15.01","price_state":"stated","total_value":83507.3056,"total_display":"83,507.31","total_whole":"83,507","shares_owned_after":322966.0,"shares_owned_after_display":"322,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-11","scope":"insider"},{"id":2969090,"accession":"0001610717-24-000490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000490","line_url":"/filing/0001610717-24-000490#line-2","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992908","owner_name":"Lenz Robert A.","owner_display_name":"Lenz Robert A.","owner_url":"/insider/0001992908","role":"Officer (Head of R&D)","role_mark":"O","role_mark_label":"Officer (Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10676.0,"shares_display":"10,676","price_per_share":12.0917,"price_display":"12.09","price_state":"stated","total_value":129090.9892,"total_display":"129,090.99","total_whole":"129,091","shares_owned_after":328529.0,"shares_owned_after_display":"328,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider"},{"id":2969086,"accession":"0001610717-24-000490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000490","line_url":"/filing/0001610717-24-000490#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992908","owner_name":"Lenz Robert A.","owner_display_name":"Lenz Robert A.","owner_url":"/insider/0001992908","role":"Officer (Head of R&D)","role_mark":"O","role_mark_label":"Officer (Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30788.0,"shares_display":"30,788","price_per_share":11.8142,"price_display":"11.81","price_state":"stated","total_value":363735.5896,"total_display":"363,735.59","total_whole":"363,736","shares_owned_after":339205.0,"shares_owned_after_display":"339,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-19","scope":"insider"},{"id":3057683,"accession":"0001610717-24-000478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000478","line_url":"/filing/0001610717-24-000478#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992908","owner_name":"Lenz Robert A.","owner_display_name":"Lenz Robert A.","owner_url":"/insider/0001992908","role":"Officer (Head of R&D)","role_mark":"O","role_mark_label":"Officer (Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32948.0,"shares_display":"32,948","price_per_share":11.4321,"price_display":"11.43","price_state":"stated","total_value":376664.8308,"total_display":"376,664.83","total_whole":"376,665","shares_owned_after":369993.0,"shares_owned_after_display":"369,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001885522","name":"Neumora Therapeutics, Inc.","url":"/issuer/0001885522","role":"Officer (Head of R&D)","n_filings":4,"first_seen":"2024-09-16","last_seen":"2025-02-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001992908","retrieved_at":"2026-08-22T18:34:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}